These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36713417)

  • 1. Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis.
    Li R; Chen Y; Zhang S; Peng L; Zhou J; Fei Y; Zhang W; Zhao Y; Zeng X
    Front Immunol; 2022; 13():1099722. PubMed ID: 36713417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
    Frątczak A; Polak K; Miziołek B; Bergler-Czop B
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan.
    Yamane T; Hashiramoto A
    Arthritis Res Ther; 2023 Jun; 25(1):110. PubMed ID: 37365612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could hypereosinophilia at diagnosis estimate the current activity or predict relapse in systemic immunosuppressive drug-naïve patients with eosinophilic granulomatosis with polyangiitis?
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Rheumatol Int; 2019 Nov; 39(11):1899-1905. PubMed ID: 31302739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis.
    Kim DS; Song JJ; Park YB; Lee SW
    Int J Rheum Dis; 2017 Sep; 20(9):1261-1268. PubMed ID: 28261989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
    BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Clinical Manifestations of Hospitalized Patients With Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study.
    Liu S; Han L; Li M; Tian X; Zeng X; Lu Y; Wang L; Zhang F
    J Rheumatol; 2023 Oct; 50(10):1318-1325. PubMed ID: 37263648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical features and treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in Turkey: one or two distinct diseases?
    Duran E; Bostan OC; Bilgin E; Kaya SB; Bolek EC; Ozer S; Damadoğlu E; Bilgen SA; Karakaya G; Karadag O
    Intern Emerg Med; 2022 Apr; 17(3):743-751. PubMed ID: 34628561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort.
    Liu S; Han L; Liu Y; Yang J; Zhang Y; Li M; Tian X; Zeng X; Wang L; Zhang F
    Front Immunol; 2022; 13():885198. PubMed ID: 35833130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm Prognosis of 121 Patients with Eosinophilic Granulomatosis with Polyangiitis in Japan.
    Tsurikisawa N; Oshikata C; Kinoshita A; Tsuburai T; Saito H
    J Rheumatol; 2017 Aug; 44(8):1206-1215. PubMed ID: 28572468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis.
    Yune S; Choi DC; Lee BJ; Lee JY; Jeon ES; Kim SM; Choe YH
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():155-62. PubMed ID: 26831057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
    Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
    Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of central nervous system involvement in patients with eosinophilic granulomatosis with polyangiitis: a retrospective cohort study in China.
    Liu S; Guo L; Fan X; Zhang Z; Zhou J; Tian X; Li M; Zeng X; Wang L; Zhang F
    Orphanet J Rare Dis; 2021 Mar; 16(1):152. PubMed ID: 33789679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis.
    Ahn SS; Song JJ; Park YB; Lee SW
    Korean J Intern Med; 2022 Nov; 37(6):1241-1249. PubMed ID: 34883552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.
    Bettiol A; Urban ML; Padoan R; Groh M; Lopalco G; Egan A; Cottin V; Fraticelli P; Crimi C; Del Giacco S; Losappio L; Moi L; Cinetto F; Caminati M; Novikov P; Berti A; Cameli P; Cathébras P; Coppola A; Durel CA; Folci M; Lo Gullo A; Lombardi C; Monti S; Parronchi P; Rivera CM; Solans R; Vacca A; Espígol-Frigolé G; Guarnieri G; Bianchi FC; Marchi MR; Tcherakian C; Kahn JE; Iannone F; Venerito V; Desaintjean C; Moroncini G; Nolasco S; Costanzo GAML; Schroeder JW; Ribi C; Tesi M; Gelain E; Mattioli I; Bello F; Jayne D; Prisco D; Vaglio A; Emmi G;
    Lancet Rheumatol; 2023 Dec; 5(12):e707-e715. PubMed ID: 38251561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.
    Grayson PC; Monach PA; Pagnoux C; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Seo P; Specks U; Ytterberg SR; Merkel PA;
    Rheumatology (Oxford); 2015 Aug; 54(8):1351-9. PubMed ID: 25406357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immune response reflects disease activity in eosinophilic granulomatosis with polyangiitis.
    Tsurikisawa N; Oshikata C; Watanabe M; Tsuburai T; Kaneko T; Saito H
    Clin Exp Allergy; 2018 Oct; 48(10):1305-1316. PubMed ID: 29908086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Mohammad AJ; Hot A; Arndt F; Moosig F; Guerry MJ; Amudala N; Smith R; Sivasothy P; Guillevin L; Merkel PA; Jayne DR
    Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurological disorders in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
    Gilyarov MY; Belikova LP; Shchukin IA; Fidler MS; Avakyan GG; Shustrova GE; Martynov MY; Svet AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):93-102. PubMed ID: 28635862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.